You are here
Shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringe for injection
Published
The pharmaceutical company Pfizer Australia has notified us of a shortage of both strengths of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringes for injection (600,000 units per syringe and 1.2 million units per syringe). Pfizer Australia has advised us that these shortages will continue into 2024.
Up-to-date information about shortage dates and the management actions we have taken is available on the medicine shortage reports database.
Important information for patients, pharmacists and prescribers is available at About the shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringe for injection.